Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Validated application protocols are not supplied for QW30 in the product data.
Item-specific test methods:
Tested applications and recommended dilutions: Not specified for this item; refer to CoA/Spec Sheet.
General protocol templates for small-molecule tool compounds (for laboratory research use only):
Preparation of DMSO stock: Weigh compound quickly to minimize moisture uptake. Dissolve to 10–50 mM in anhydrous DMSO, vortex, and sonicate briefly if needed. Filter through 0.2 µm PTFE into low-bind microtubes. Aliquot and store at -20°C.
Biochemical assay dosing: Prepare serial dilutions in assay buffer keeping final DMSO ≤0.1–0.5% v/v. Include vehicle controls and a known positive control when available. Incubate per assay SOP and read out using appropriate detection (fluorescence, absorbance, luminescence, MS).
Cell-based assay dosing: Pre-dilute compound in media to limit DMSO shock; verify absence of precipitation microscopically. Include cytotoxicity counterscreens to rule out non-specific effects.
Stability check: After assay setup, sample the highest and mid concentrations and analyze by LC/MS to confirm compound integrity during the assay window.
Replace these general templates with method-specific SOPs once the intended application of QW30 is defined.
Biological Roles
The product data for QW30 do not specify a biological target, pathway, or functional class. Therefore, no item-specific biological role can be claimed. The following considerations are general and intended to guide experimental planning when working with an undisclosed small-molecule research reagent.
Potential use as a research tool compound: If QW30 has a defined target in the literature (consult publications indexed by CAS 1714112-25-0), validate activity in your hands with orthogonal assays (biochemical and cellular) and determine on-target potency versus counterscreens for selectivity.
Physicochemical profiling: Measure solubility in assay buffer, stability across pH 5–8, and plasma/protein binding if relevant to ex vivo studies. These properties can significantly influence apparent activity and should be characterized prior to interpreting results.
Off-target assessment: Employ broad counter-panels (e.g., cytotoxicity, frequent hitter filters, PAINS substructure checks if structure is known) to minimize artifactual readouts.
Vehicle and controls: Maintain constant vehicle concentration (often ≤0.1–0.5% DMSO) across dose-responses; incorporate positive/negative controls and replicate measurements.
Data integrity: Track lot numbers, storage time at -20°C, freeze–thaw cycles, and solution age to correlate any activity shifts with material history.
No medical or clinical claims are made for this material. For research use only.
Buffer Applications
Buffer usage is not typically applicable without knowing the compound’s acid/base properties. For QW30, no pKa, ionic state, or buffering capacity data are provided.
Item-specific buffering role: Not specified for this item; refer to CoA/Spec Sheet.
General guidance:
If QW30 is used in biochemical assays, it will more likely be solubilized in a buffer rather than function as a buffer. Select buffering systems compatible with the biology (e.g., HEPES, Tris, PBS) and with QW30’s stability profile.
For weak acids/bases, apparent solubility and activity can vary with pH. Perform a pH-solubility screen (e.g., pH 5, 6, 7.4, 8) using 1–10% co-solvent to define workable conditions.
Avoid primary amine-containing buffers (e.g., Tris) if QW30 bears activated esters or electrophiles that may react with nucleophiles; choose HEPES or phosphate instead.
Conclusion: No dedicated buffer formulation is associated with QW30 in the product data. Use standard biochemical buffers and verify compatibility experimentally.
Green Alternatives
Because the identity and typical use of QW30 are not disclosed, green chemistry considerations focus on solvents, handling, and process choices surrounding its use rather than the molecule itself.
Greener solvent strategy (general guidance):
Prefer bio-based, higher-boiling ethers/esters where compatible: 2-MeTHF or CPME instead of THF; ethyl acetate over dichloromethane when extraction/flash chromatography allow.
Replace DMF/NMP where possible with safer polar aprotic alternatives (e.g., dimethyl carbonate, propylene carbonate, sulfolane blends) if the solubility profile permits.
Use aqueous media or water-miscible alcohols (EtOH, i-PrOH) when stability allows; add small DMSO fractions for difficult solubilization.
Operational improvements:
Minimize DMSO content in bioassays (≤0.1–0.5% v/v) to reduce environmental burden and biological confounding.
Implement microscale reactions and high-throughput experimentation to cut solvent volumes and energy.
Employ solid-phase or flow techniques when feasible to reduce solvent usage and enable better heat/mass transfer.
Illustrative comparison (general):
DCM vs EtOAc: EtOAc offers lower toxicity and can substitute for many extractions/flash gradients, albeit with higher polarity and sometimes lower selectivity.
THF vs 2-MeTHF: 2-MeTHF is less prone to peroxide formation and is partially bio-based; however, it has higher UV absorbance and a distinct odor, and may not dissolve very polar substrates as well.
Note: Select alternatives only after confirming QW30’s solubility and stability in the proposed medium.
Pharmaceutical Uses
No pharmacopeial status, excipient role, or formulation guidance is provided for QW30. This product is supplied strictly for research use.
Item-specific information:
Regulatory listing (USP/EP/JP): Not specified for this item; refer to CoA/Spec Sheet.
Excipient/functionality class: Not specified for this item; refer to CoA/Spec Sheet.
General considerations for small molecules in pre-formulation research (non-clinical, non-human use):
Solubility enhancement strategies: Co-solvents (e.g., PEG 400, ethanol, propylene glycol), cyclodextrin inclusion, or salt formation if ionizable. Confirm chemical stability and avoid reactive excipients.
Solid-state characterization: If planning solid dosage research, map polymorphism/amorphism by PXRD/DSC/TGA; evaluate hygroscopicity.
Stability: Conduct ICH-like stress screens (light, heat, oxidative, pH) to identify liabilities; store under inert atmosphere if oxidation is observed.
Analytical controls: Establish stability-indicating HPLC/UPLC methods with MS detection for degradant tracking.
Important: No medical, diagnostic, or therapeutic claims are made. QW30 is for laboratory research use only and is not intended for human or animal administration.
Physical Properties
Only limited item-specific physical data are provided for this product. Do not treat literature values as specifications.
Item-specific (as listed):
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight (catalog): Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed values (for this exact CAS):
Not provided here. If you source literature values, ensure they correspond to the same form (free base vs. salt, hydrate/solvate) and supplier.
General guidance for unknown/undisclosed small molecules (literature-level practices):
Melting point (solids): Typically measured by DSC or capillary; use as an identity/polymorph check rather than an absolute spec unless defined.
Boiling point (liquids): If applicable, record under reduced pressure to avoid decomposition.
Solubility screening: Begin with DMSO, DMF, ethanol, methanol, acetonitrile, isopropanol, and water at room temperature. For buffers, test PBS (pH 7.4), HEPES (pH 7.4), and acetate (pH 5.0) with and without 0.1–1% co-solvent or 0.01–0.1% non-ionic surfactant.
LogP/logD, pKa: If needed for ADME modeling or assay design, determine experimentally (shake-flask or potentiometric titration) or compute, then verify experimentally for critical work.
Note: When using any physical constants operationally (e.g., for dosing or formulation), rely on the lot-specific CoA/specification when available.
Quality and Grades
Item-specific grade and purity details are not provided in the data for QW30.
Item-specific statements:
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
How to interpret common grades (general guidance):
Research grade: Suitable for most discovery and screening work; purity typically reported by HPLC/UPLC with a specified detection method (UV/ELSD/MS). Verify residual solvents and counterion content as needed.
Analytical (AR) grade: Tight control on inorganic contaminants; used for quantitative analytical workflows.
HPLC grade solvent/reagent: Optimized for low UV cutoff/low residue; not directly applicable unless QW30 is supplied as a solution.
BioXtra/Cell culture tested: Where applicable, indicates testing for endotoxin/bioburden; no such claim is listed here.
Verification best practices:
Request the lot-specific CoA for identity (NMR/HRMS), purity (% area by a stated method), water content (KF), and residual solvents if relevant to your use case. If trace metals matter (e.g., catalysis), seek ICP-MS data.
Stabilizers: Not specified for this item; refer to CoA/Spec Sheet. If present, they can influence UV absorbance and bioassay results—account for them in controls.
Conclusion: In the absence of declared grade, treat QW30 as a research-use reagent and qualify it internally for critical applications.
Reaction and Applications
Manufacturer-supplied application notes for QW30 are not provided. Without structural information, reaction chemistry cannot be specified. The following guidance is generalized for small-molecule research reagents used in discovery and assay development.
Potential laboratory applications (general):
As a biochemical tool compound or screening hit: Prepare DMSO stocks (e.g., 10–50 mM), verify identity/purity, and assess stability in assay buffer by LC/MS over time.
Analytical characterization: Establish retention time and purity by orthogonal HPLC methods (C18 reversed-phase with aqueous-organic gradients; consider phenyl-hexyl or HILIC if highly aromatic or polar, respectively).
If QW30 is a synthetic intermediate (unknown): Evaluate functional group compatibility with common transformations under mild conditions first (amide couplings, SNAr, Suzuki if aryl halide present, etc.) only after structure verification.
Practical tips (general):
Drying: If moisture sensitivity is suspected (e.g., rapid HPLC drift or haze in DMSO/water), dry reagents and solvents (3 Å or 4 Å molecular sieves) and handle under inert gas.
Stability: Conduct forced-degradation microstudies (light, pH extremes, oxidative peroxide challenge) to map liabilities before critical experiments.
Controls: Include vehicle controls (matching DMSO %) and, where available, inactive analogs to separate on-target from off-target effects in biochemical assays.
Note: For any named reaction use or mechanistic claims, consult primary literature specific to the verified structure and lot of QW30.
Reaction Conditions
Specific reaction conditions for QW30 cannot be provided without structural information. The following are general, literature-informed ranges for common small-molecule transformations; they are not specifications and should be validated experimentally.
General condition ranges (literature-level guidance):
Amide coupling: EDCI/HOBt-alternative (e.g., Oxyma) or HATU, DIPEA or TEA, DMF/DCM/MeCN, 0–25°C, 1–16 h. Monitor by LC/MS.
Suzuki–Miyaura coupling (if aryl/vinyl halide/boronate present): Pd(PPh3)4 or Pd-PEPPSI, base (K2CO3, K3PO4), 1,4-dioxane/H2O or EtOH/H2O, 50–100°C, 2–12 h.
Buchwald–Hartwig amination: Pd2(dba)3/XPhos or BrettPhos, NaOtBu or K3PO4, toluene/dioxane, 60–110°C, 4–24 h.
Hydrogenation (if reducible unsaturation): Pd/C or PtO2, H2 1–5 bar, MeOH/EtOH/EtOAc, 20–40°C, 1–8 h.
Reductive amination: NaBH3CN or BH3·THF, MeOH/MeCN, pH 5–6 (AcOH), 0–25°C, 1–6 h.
Stock solutions: 10–50 mM in DMSO, filter 0.2 µm PTFE, store at -20°C in aliquots.
Working solutions: Dilute into buffer to final DMSO ≤0.1–0.5% v/v; confirm solubility and absence of precipitate by visual check and UV/LC.
Reminder: Replace these general ranges with structure-appropriate conditions once QW30’s identity is verified.
Safety and Handling
Hazard classification details are not supplied in the product data and may vary with form and impurities. Always review the SDS for the specific lot before use.
Item-specific safety fields:
GHS Classification: Not specified for this item; refer to SDS.
Signal word: Not specified for this item; refer to SDS.
Hazard statements (H-codes) and pictograms: Not specified for this item; refer to SDS.
General laboratory precautions (applicable to unknown small-molecule research reagents):
PPE: Lab coat, safety glasses or splash goggles, and appropriate chemically resistant gloves (e.g., nitrile). Work in a certified fume hood to minimize inhalation exposure and avoid aerosol generation.
Incompatibilities: Unknown without structural information. As a conservative practice, segregate from strong oxidizers, strong acids/bases, and reducing agents until compatibility is known. Avoid heat, sparks, and open flames if volatility or flammability is suspected.
First aid (overview; follow SDS): If inhaled—fresh air; if on skin—wash with soap/water; if in eyes—rinse cautiously for 15 minutes; if ingested—rinse mouth and seek medical advice. Provide the SDS to medical responders.
Spill/cleanup: Contain with inert absorbent, avoid dust, collect for disposal per institutional and local regulations.
Waste: Dispose of as organic laboratory chemical waste unless SDS indicates otherwise.
Note: No medical or clinical use. For research use only.
Solvent Selection
No solubility or polarity data are provided for QW30. The following is a practical solvent-screening approach for an unknown small-molecule research reagent.
Aqueous systems: PBS pH 7.4, HEPES pH 7.4, acetate buffer pH 5.0, with 0–10% co-solvent (DMSO, ethanol) as needed.
If lipophilicity is suspected (oily residue, hydrophobic behavior): Try MTBE, toluene, 2-MeTHF, CPME; for bases/acids, explore slightly acidic/basic aqueous solutions to form salts in situ.
Decision tips (general):
Create 10 mM stock solutions in DMSO when structure is unknown; this is broadly compatible with biochemical assays. Filter stocks (0.2 µm PTFE) if particulate remains.
For chromatography or reaction workups, start with EtOAc/hexanes or MeOH/DCM gradients, then refine by TLC polarity behavior.
Avoid strong acids/bases until stability is known; monitor by LC/MS for degradation.
Small comparison (general considerations):
DMSO vs DMF: DMSO favored for bioassays (lower volatility, common vehicle); DMF can be more aggressive and moisture-sensitive for long-term storage.
MeOH vs EtOH: MeOH offers higher polarity but can methylate under strongly acidic/basic conditions; EtOH is milder but less polar.
Note: Treat any observed solubility as method-specific, not a specification, unless confirmed on the CoA.
Storage and Reconstitution
Item-specific storage/shipping information:
Storage Conditions: Store at -20°C (as provided in product data).
Physical form, stabilizers, and reconstitution solvent: Not specified for this item; refer to CoA/Spec Sheet.
General best practices for small-molecule research reagents:
Solid material: Store tightly sealed at -20°C in a desiccator or with desiccant to limit moisture uptake. Protect from light if chromophores are suspected; use amber vials.
Solutions: If supplied or prepared in solution (e.g., DMSO), aliquot into low-bind tubes to avoid repeated freeze–thaw. Typical working stocks are 10–50 mM in anhydrous DMSO; verify solubility visually and by LC/UV.
Reconstitution (generic): Bring vial to room temperature in a desiccator, briefly centrifuge to collect contents, add a measured volume of an appropriate solvent (start with dry DMSO or ethanol), vortex and, if needed, sonicate. Filter through 0.2 µm PTFE for sterile or particle-free applications.
Stability tracking: Label aliquots with preparation date and concentration. Periodically assess purity by HPLC/LC–MS, especially after >6 months at -20°C or >1 week at 4°C.
Note: For research use only. Follow the lot-specific CoA/SDS for authoritative storage and handling directions.
Structure and Identity
Item-specific identifiers provided for this listing are limited. Where exact identifiers are not supplied below, consult the current CoA/Specification Sheet or SDS for authoritative details.
Product Name: QW30 (catalog research reagent)
CAS: 1714112-25-0
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChI / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Synonyms: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general guidance):
Structural class, ring systems, and functional groups are not disclosed in the product data. If you are correlating literature data to this CAS, verify the supplier-specific structure assignment as CAS-level records can encompass multiple salt forms or solvates in different catalogs.
For spectral verification, we recommend routine small-molecule QC: 1H/13C NMR, HRMS, and, when applicable, IR and HPLC/UPLC purity determination using orthogonal methods (UV and ELSD). If chirality is suspected, include chiral HPLC or optical rotation.
2D structure description (general):
Not specified for this item. If a structure is known to your program, document functional handles (e.g., amide, heteroaryl, halogen) to anticipate solubility and reactivity behavior in downstream assays.
Synthetic Utility
The product data do not disclose the structure or functional groups of QW30, so specific synthetic transformations cannot be recommended. The following are general strategies if QW30 is intended as a building block or an intermediate (verify structure first).
General retrosynthetic/value considerations:
If QW30 contains common handles (e.g., aryl halide, boronate, vinyl group, nitrile, carboxyl, amine), standard cross-couplings (Suzuki–Miyaura, Buchwald–Hartwig, Sonogashira), nucleophilic substitutions, or amide couplings may be applicable.
For heteroaromatic scaffolds, SNAr or directed metalation can enable diversification when positions are activated.
If chiral, preserve stereochemical integrity using mild coupling reagents, and monitor epimerization by chiral HPLC or 2D NMR.
Practical tips:
Establish a stability map before synthesis (sensitivity to strong base, acid, or oxidants). Begin with neutral or mildly basic conditions and room temperature.
Use anhydrous conditions and dry solvents where hydrolysis is a risk (e.g., acid chlorides, activated esters). Additives such as HOAt/HOBt alternatives (e.g., Oxyma) can improve coupling efficiency if amide formation is relevant.
Purification: Optimize with orthogonal methods—normal-phase silica for nonpolar species; reversed-phase flash/prep LC for polar or zwitterionic species.
Note: Replace this general guidance with structure-specific routes once the identity of QW30 is confirmed via CoA.
Target Specificity
Target-related information is not provided for QW30.
Item-specific details:
Target/antigen, pathway, enzyme class: Not specified for this item; refer to CoA/Spec Sheet and primary literature for CAS 1714112-25-0.
Clone/isotype/species reactivity: Not applicable; QW30 is not listed as an antibody or protein reagent.
General guidance for small-molecule target validation:
Confirm target engagement using orthogonal assays (e.g., biochemical IC50/Ki, biophysical SPR/DSF/ITC, cellular target engagement such as CETSA or NanoBRET where suitable).
Evaluate selectivity across close homologs or family panels to benchmark specificity.
Use inactive analogs or competition experiments to validate on-target mechanism and minimize false positives due to aggregation or redox cycling.
Conclusion: No target specificity claims are made for this product. For research use only.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
